XML 19 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Unaudited Condensed Consolidated Statements of Stockholders' Equity Statement - USD ($)
shares in Thousands, $ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock
Capital in Excess of Par Value
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Total  Synopsys Stockholders’ Equity
Total  Synopsys Stockholders’ Equity
Cumulative Effect, Period of Adoption, Adjustment [Member]
Non-controlling Interest
Balance (in shares) at Oct. 31, 2019     150,331                
Beginning balance at Oct. 31, 2019 $ 4,088,876   $ 1,503 $ 1,635,455 $ 3,164,144   $ (625,642) $ (92,447) $ 4,083,013   $ 5,863
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 104,061       104,061       104,061    
Other comprehensive income (loss), net of tax effects $ 9,136             9,136 9,136    
Purchases of treasury stock (in shares) (579)   (579)                
Purchases of treasury stock $ (80,000)   $ (6) 6     (80,000)   (80,000)    
Equity forward contract $ (20,000)     (20,000)         (20,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 450   450                
Common stock issued, net of shares withheld for employee taxes $ 734   $ 5 (40,561)   41,290   734    
Stock-based compensation 51,883     51,883         51,883    
Balance (in shares) at Jan. 31, 2020     150,202                
Ending balance at Jan. 31, 2020 4,154,690   $ 1,502 1,626,783 3,268,205   (664,352) (83,311) 4,148,827   5,863
Balance (in shares) at Oct. 31, 2020     152,618                
Beginning balance at Oct. 31, 2020 4,912,367   $ 1,528 1,653,166 3,795,397   (488,613) (54,074) 4,907,404   4,963
Beginning balance (Retained earnings adjustment due to adoption of ASC 326) at Oct. 31, 2020 [1]   $ (3,200)       $ (3,200)       $ (3,200)  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Net income 162,028       162,345       162,345   (317)
Other comprehensive income (loss), net of tax effects $ 19,299             19,299 19,299    
Purchases of treasury stock (in shares) (837) [2]   (837)                
Purchases of treasury stock $ (202,871) [2]   $ (8) 8     (202,871)   (202,871)    
Equity forward contract $ (50,000)     (50,000)         (50,000)    
Common stock issued, net of shares withheld for employee taxes (in shares) 583 [2]   583                
Common stock issued, net of shares withheld for employee taxes $ (34,507)   $ 6 (97,781)   63,268   (34,507)    
Stock-based compensation 83,782     83,782         83,782    
Balance (in shares) at Jan. 31, 2021     152,364                
Ending balance at Jan. 31, 2021 $ 4,886,898   $ 1,526 $ 1,589,175 $ 3,954,542   $ (628,216) $ (34,775) $ 4,882,252   $ 4,646
[1] In June 2016, the Financial Accounting Standards Board (FASB) issued ASC 326, "Measurement of Credit Losses on Financial Instruments", which replaces the incurred loss methodology with an expected loss methodology. The Company adopted the new standard at the beginning of fiscal 2021.
[2] Does not include the $50.0 million equity forward contract, from the December 2020 ASR.